YBX1 and hepatocellular carcinoma: Linc01612 promotes the ubiquitination and proteasome pathway degradation of YBX1, thereby reducing YB1 protein stability, reducing YB1 protein levels, but not affecting its RNA expression levels, exerting its inhibitory effect in hepatocellular carcinoma (36).